Skip to main content

Coherus Oncology, Inc 10-Q for FY2026 Q2

Coherus Oncology, Inc. (CHRS)

10-Q 2026-08-05 For: 2026-06-30
View Original
Added on August 05, 2026

About this 10-Q

Coherus Oncology, Inc filed this 10-Q on August 5, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$14.31M
up 39.5% from $10.25M a year earlier
Net loss
$20.63M
compared with net income of $297.77M a year earlier
Diluted EPS
-$0.13
compared with $2.57 a year earlier